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An outbreak of respiratory illness occurred in a long-
term care facility in New York City. Investigation of the out-
break identified confirmed or suspected adenoviral infec-
tion in 84% of the residents from October 19 to December
18, 1999. Further identification by type-specific neutraliza-
tion and restriction analysis identified a new genomic vari-
ant of adenovirus type 7. 
H
uman adenoviruses are known to cause a variety of
illnesses, including cystitis, diarrhea, intussusception,
meningoencephalitis, epidemic keratoconjunctivitis, and
encephalitis (1). Communitywide outbreaks of respiratory
illness attributable to adenovirus, particularly serotypes 3,
4, 7, and 21, have also been described in civilian (2,3) and
military (4) populations. Institutional outbreaks involving
pediatric populations or persons with underlying pul-
monary disease can be particularly severe, with high ill-
ness and death rates (5,6). 
On November 27, 1999, three residents in the specialty
hospital of a large long-term care facility in New York City
were hospitalized with respiratory failure. When addition-
al illnesses were identified, control measures and an out-
break investigation were initiated. We present the results of
that investigation and document a novel genome type of
adenovirus serotype 7 (Ad7) as the etiologic agent of the
outbreak.
The Study
Chart reviews were conducted for all residents of the
specialty hospital and retrospectively for persons who had
died or were discharged in the previous 2 months. A con-
firmed case-patient was defined as a resident of the spe-
cialty hospital in whom new respiratory symptoms devel-
oped from October 19, 1999, to January 10, 2000, and who
had a positive laboratory test for adenovirus or a
histopathologic finding that was indicative of adenovirus
infection. A suspected case-patient was defined as a resi-
dent of the specialty hospital in whom new respiratory
symptoms developed from October 19, 1999, to January
10, 2000, and who tested negative for adenovirus or was
not tested. A noncase-patient was defined as anyone with-
out respiratory symptoms, regardless of test results, or any-
one with respiratory symptoms and with an organism other
than adenovirus identified through laboratory testing in the
same period.
Specimens initially were requested only from sympto-
matic residents. As the outbreak continued, we attempted
to obtain specimens from all residents in an effort to iden-
tify carriers. Nasal washings or tracheal secretions were
tested for respiratory syncytial virus (RSV), influenza A
and B, parainfluenza 1, 2, and 3, and adenovirus antigens
by a commercial immunofluorescence assay (VRK Bartels
Viral Respiratory Screening and Identification Kit, Bartels
Inc., Issaquah, WA) and by enzyme immunoassay
(Directigen RSV, Becton Dickinson, Le Pont de Claix,
France) for RSV. Specimens were also added to MRC5,
RMK, and A549 cells, and the cells were monitored for
cytopathic effect. Selected specimens were tested for ade-
novirus by polymerase chain reaction (PCR) assay, using
adenovirus group- and Ad7-specific primer sets (7,8).
Autopsied lung tissue specimens also were sent to the
Centers for Disease Control and Prevention (CDC) for rou-
tine histopathologic examination.
Adenovirus isolates were typed by use of a microneu-
tralization assay (9). Genome typing by restriction analysis
was performed by using 12 restriction enzymes, BamHI,
BcII, BgI, BglII, BstEII, EcoRI, HindIII, HpaI, SalI, SmaI,
XbaI , and XhoI, as previously described (5). Restriction
patterns were interpreted by using the genome type classi-
fication scheme of Li and Wadell (10) and Li et al. (11). An
additional 27 unrelated Ad7 community isolates collected
between 1995 and 2000 were provided by several health-
care centers in the New York City area for comparison
with the outbreak strains. Data were analyzed by using
EpiInfo version 6.04b (CDC) for descriptive statistics.
Of the 50 residents in the specialty hospital from
October 19, 1999, to January 10, 2000, 23 (46.0%) were
females and 27 (54.0%) were males. Their ages ranged
from 1 to 46 years (mean 11; median 10). The residents
were located in two units: A with 21 (42.0%) and B with
29 (58.0%) residents. On average, the residents in B were
younger than those in A (mean age 7 years [median 5;
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42nd Street Lower Suite, Brooklyn, NY 11203, USA.range 1-32] versus mean age 16 years [median 14; range 3-
46]).
Of the 50 residents, 30 (60.0%) had confirmed cases of
adenovirus infection, 12 (24.0%) had suspected cases, and
8 (16.0%) did not have adenovirus. Of the 30 patients with
confirmed cases, 19 (63.3%) were hospitalized, and 5 died
(confirmed case-fatality rate, 16.7%). Of the 12 patients
with suspected cases, 7 (58.3%) were hospitalized and 2
died (suspected case-fatality rate, 16.7%). Of the eight
noncase-patients, one person (12.5%) exhibited respirato-
ry symptoms and was confirmed to be infected with herpes
simplex virus; the other seven (87.5%) exhibited no respi-
ratory symptoms, and three of six tested positive for aden-
ovirus.
Confirmed case-patients were on average younger than
suspected and noncase-patients (mean age 9 years [median
6; range 1-32] versus 12 years [median 12; range 1-25] and
13 years [median 12; range 1-6], respectively. More than
80% of confirmed and suspected case-patients had a tra-
cheostomy, versus 37% of noncase-patients. 
Symptom onset dates for residents with respiratory ill-
ness ranged from October 19, 1999, to December 18, 1999
(Figure 1). The Table describes the clinical characteristics
of confirmed and suspected case-patients. The mean dura-
tion of illness for confirmed patients was 21 days (median
20; range 2-62) versus 28 days (median 22; range 6-93) for
suspected case-patients.
Specimens from 48 (96.0%) of the 50 residents were
submitted for testing. Of them, 26 (60.5%) of 43 were ade-
novirus positive by culture, 13 (54.2%) of 24 were positive
by adenovirus group–specific PCR, 6 (22.2%) of 27 were
positive by antigen testing, and 3 (100%) of 3 were posi-
tive by histopathology. Overall, 33 (68.8%) persons tested
positive for adenovirus. Of 15 outbreak isolates submitted
to CDC for further characterization, all were identified as
serotype 7 by type-specific neutralization. Restriction
analysis with 12 previously described restriction enzymes
further identified all isolates as SmaI variants of genome
type 7b (Figure 2). Restriction patterns obtained with 11
other enzymes were identical with those predicted for
genome type 7b (12,13). Of the 28 additional Ad7 field
isolates from the New York City area that were epidemio-
logically unrelated to the outbreak, 24 were identified as
Ad7b and 4 as Ad7d2; none possessed the unique SmaI
restriction pattern of the outbreak strain (data not shown).
Conclusions 
This outbreak illustrates the difficulty inherent in con-
trolling the spread of adenovirus in a closed community
and the potential for severe disease and death in persons
with underlying respiratory disease. When both confirmed
and suspected cases are included, a remarkably high attack
rate of 84% was documented among the 50 residents of the
specialty hospital, with 26 hospitalizations and 7 deaths.
The epidemiologic association and similar hospitalization
and fatality rates for confirmed and suspected cases sup-
port our conclusion that most suspected cases likely had
adenovirus infections. 
A possible explanation for the 1-month lapse between
the initial case in October and the other cases may be that
the virus was first introduced into the facility in October
but was transmitted more efficiently during the colder
months, when there were more indoor activities and
crowding on the units. A previously published report of an
outbreak in a chronic-care facility (5) identified younger
age and tracheostomy as risk factors for adenovirus infec-
tion. The high attack rate in this outbreak prevented calcu-
lation of risk factors. However, we observed a higher per-
centage of confirmed cases among the younger residents
and persons with a tracheostomy. Therefore, we conclude
that the underlying chronic respiratory disease in this pop-
ulation facilitated the transmission of this pathogen and
that Ad7b variant may represent an emerging risk to simi-
lar persons.
The Ad7b genome type is widely distributed geograph-
ically and has been the predominant strain circulating in
the United States since the late 1960s (12,13) (D. Erdman,
pers. observation). Although genetic variants of Ad7b have
been described using other restriction enzymes (12), to our
knowledge, this is the first description of the SmaI variant
of Ad7b. The novel SmaI pattern was most likely derived
from the loss of the single restriction site that forms frag-
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Figure 1. Epidemic
curve showing onset




City, 1999.ments 12,700 bp and 2,500 bp; loss of these two fragments
corresponded with the appearance of a new 15,200-bp
fragment. Failure to identify this variant in past studies or
among recent Ad7s isolates circulating in the New York
community suggests that it arose recently and supports the
hypothesis that this outbreak resulted from nosocomial
spread of the virus within the chronic care unit. Whether
the genetic mutation(s) in the outbreak strain contributed
to the severity of illness documented in these patients
could not be determined. 
Adenoviruses cause severe and often fatal respiratory
disease in immunocompromised patients (1). A large out-
break of acute respiratory disease and pneumonia at a
chronic mental health facility recently was attributed to
adenovirus 35, a pathogen that has typically affected
immunocompromised patients (14). Investigators specu-
lated that immunity to Ad35 may have waned in the long-
term residents, who may have been less likely to have been
exposed to adenoviruses circulating in the community. 
Recent outbreak investigations and surveillance studies
(15) suggest that certain U.S. populations at risk may be
experiencing an increase in acute respiratory disease
caused by adenoviruses. In settings such as long-term care
facilities that house patients with susceptible underlying
conditions, infection with virulent adenoviral strains
should be considered when patients are seen with sudden
respiratory disease, and appropriate control measures
should be implemented quickly, pending pathogen identi-
fication. 
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Figure 2. DNA fragment patterns obtained with selected restriction
enzymes of representative outbreak (1) and community (2) Ad7 iso-
lates resolved by gel electrophoresis with ethidium bromide stain-
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strain (1) as compared with the expected pattern for Ad7b (2).
Table. Clinical characteristics of the confirmed and suspected 
adenovirus case-patients in a specialty hospital unit of a long-





(N = 30) 
Suspected (%) 
(N = 12) 
Female  13 (43.3)  5 (41.7) 
Male  17 (56.7)  7 (58.3) 
Mean age, in y  9  12 
Median (range)  6 (1–32)  12 (1–25) 
Fever >38.3°C  30 (100.0)  11 (91.7) 
Increased tracheal secretions  24 (80.0)  10 (83.3) 
Chest congestion  23 (76.7)  11 (91.7) 
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Wheezing  16 (53.3)  5 (41.2) 
Cough  9 (30)  4 (33.3) 
Nasal congestion  2 (6.7)  0 
Runny nose  1 (3.3)  1 (8.3) 
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